Abstract

Metastasis is the leading cause of high mortality in breast cancer patients. As is shown by numerous clinical studies and research data, intra-tumor hypoxia is closely related to the fatality rate of breast cancer patients, which may suggest that HIF-1α expression plays a contributory role in breast cancer metastasis. DATS was screened out from the garlic fat-soluble components on the basis of HIF-1α transcriptional activity. DATS not only demonstrated that it could effectively inhibit HIF-1α transcriptional activity, but that it also affected the mRNA levels of its direct target genes LOX, ANGPTL4 and LOXL-4 to varying degrees. DATS attenuated the metastatic potential of MDA-MB-231 cells in hypoxia-induced embryonic zebrafish assays, xenograft and orthotopic tumor assays. Those results also showed that DATS could dose-dependently inhibit the migration and angiogenesis of MDA-MB-231 cells using EC-cancer cell adhesion, wound-healing, transwell and tube formation in vitro experiments. Inhibition of L1CAM, EMT-related proteins (Slug, Snail, MMP-2) and VEGF-A protein expression was also induced by DATS. DATS modulates HIF-1α not only at the protein level but also via direct inhibition of its activity through its effects on upstream Trx-1 protein level. DATS also inhibits the enzyme activity of Trx reductase in breast cancer cells. In keeping with reduced Trx-1 nuclear translocation from cytoplasm by DATS, the production of the reduced form of Trx-1 was dramatically decreased. Collectively, this present study indicates that targeting the Trx system with DATS may provide a promising strategy for treating metastasis in breast cancer.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.